FR2429591A1 - CANCER TREATMENT METHOD AND COMPOSITION - Google Patents
CANCER TREATMENT METHOD AND COMPOSITIONInfo
- Publication number
- FR2429591A1 FR2429591A1 FR7819704A FR7819704A FR2429591A1 FR 2429591 A1 FR2429591 A1 FR 2429591A1 FR 7819704 A FR7819704 A FR 7819704A FR 7819704 A FR7819704 A FR 7819704A FR 2429591 A1 FR2429591 A1 FR 2429591A1
- Authority
- FR
- France
- Prior art keywords
- composition
- particles
- cancer
- treatment method
- cancer treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
- A61N1/403—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
- A61N1/406—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia using implantable thermoseeds or injected particles for localized hyperthermia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'invention se rapporte à un procédé et à une composition de traitement du cancer. Elle est caractérisée en ce qu'on introduit à l'intérieur des cellules de tissus vivants de petites particules ayant des propriétés ferromagnétiques, paramagnétiques ou diamagnétiques, et en ce qu'on assure leur chauffage inductif en les soumettant à un champ électromagnétique alternatif de haute fréquence, une amélioration de la sélectivité et de l'affinité des cellules cancéreuses pour les particules pouvant être obtenue par incorporation de radioisotopes ou d'anticorps spécifiques auxdites particules. L'invention se rapporte au traitement du cancer.The invention relates to a method and composition for treating cancer. It is characterized in that small particles having ferromagnetic, paramagnetic or diamagnetic properties are introduced inside the cells of living tissues, and in that their inductive heating is ensured by subjecting them to an alternating electromagnetic field of high frequency, an improvement in the selectivity and the affinity of the cancer cells for the particles which can be obtained by incorporating radioisotopes or antibodies specific to said particles. The invention relates to the treatment of cancer.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782828941 DE2828941A1 (en) | 1978-06-30 | 1978-06-30 | CANCER TREATMENT AGENTS |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2429591A1 true FR2429591A1 (en) | 1980-01-25 |
FR2429591B1 FR2429591B1 (en) | 1981-06-26 |
Family
ID=6043278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7819704A Granted FR2429591A1 (en) | 1978-06-30 | 1978-06-30 | CANCER TREATMENT METHOD AND COMPOSITION |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE2828941A1 (en) |
FR (1) | FR2429591A1 (en) |
GB (1) | GB2024007B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2508802A1 (en) * | 1981-07-03 | 1983-01-07 | Thomson Csf | Magnetic powders for use in hyperthermic treatments - e.g. of tumours, heated by hysteresis in alternating magnetic field |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4323056A (en) * | 1980-05-19 | 1982-04-06 | Corning Glass Works | Radio frequency induced hyperthermia for tumor therapy |
WO1983001738A1 (en) * | 1981-11-12 | 1983-05-26 | SCHRÖDER, Ulf | Intravascularly administrable, magnetically responsive nanosphere or manoparticle, a process for the production thereof, and the use thereof |
DE3709851A1 (en) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | NMR DIAGNOSTIC LIQUID COMPOSITIONS |
DE4419256A1 (en) * | 1994-06-01 | 1995-12-07 | Rau Freiherr Von Nagell Helmut | Intravenous admin of iron |
AU4067999A (en) | 1998-04-03 | 1999-10-25 | Du Pont Pharmaceuticals Company | Inorganic material for radioactive drug delivery |
CA3009649A1 (en) | 2015-12-23 | 2017-06-29 | Brown University | Thermal accelerant compositions and methods of use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3474777A (en) * | 1966-02-10 | 1969-10-28 | Amp Inc | Method of administering therapeutic agents |
US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
FR2316974A1 (en) * | 1975-07-11 | 1977-02-04 | Leveen Harry | PROCESS FOR TREATMENT OF TUMORS BY DIATHERMIA |
FR2321305A1 (en) * | 1975-08-04 | 1977-03-18 | Critical Systems | METHOD AND APPARATUS FOR HEATING TISSUES, IN PARTICULAR FOR TREATMENT OF TUMORS |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3294686A (en) * | 1966-12-27 | Pigment particles coated with organo-alumtnum compounds | ||
DE1284528B (en) * | 1967-03-08 | 1968-12-05 | Foerster | Device for the elimination of biological tissue by inductively heated bodies with temperature stabilizing properties |
DE1692771A1 (en) * | 1968-02-24 | 1972-01-05 | Willy Dr Med Seuss | Process for the preparation of internally or externally applicable physiologically active substances and agents manufactured according to them |
SE372421B (en) * | 1968-04-01 | 1974-12-23 | Minnesota Mining & Mfg | |
US3720761A (en) * | 1968-10-14 | 1973-03-13 | W Hunter | Injectable radio-pharmaceutical scanning agent and preparation |
GB1270410A (en) * | 1969-09-25 | 1972-04-12 | Allor Corp | Colloidal composition and method of preparing the same |
US3743714A (en) * | 1970-12-04 | 1973-07-03 | Cis Radiopharmaceuticals Inc | Novel carrier preparations for injectable radioactive compositions |
US3927193A (en) * | 1973-05-18 | 1975-12-16 | Hoffmann La Roche | Localization of tumors by radiolabelled antibodies |
SE431214B (en) * | 1977-06-02 | 1984-01-23 | Klaus H Mosbach | SET TO MAKE MAGNETIC POLYMER PARTICLES BASED ON A PREFERRED BIOLOGY ACTIVE SUBSTANCE |
-
1978
- 1978-06-27 GB GB7828040A patent/GB2024007B/en not_active Expired
- 1978-06-30 DE DE19782828941 patent/DE2828941A1/en active Granted
- 1978-06-30 FR FR7819704A patent/FR2429591A1/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3474777A (en) * | 1966-02-10 | 1969-10-28 | Amp Inc | Method of administering therapeutic agents |
US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
FR2316974A1 (en) * | 1975-07-11 | 1977-02-04 | Leveen Harry | PROCESS FOR TREATMENT OF TUMORS BY DIATHERMIA |
FR2321305A1 (en) * | 1975-08-04 | 1977-03-18 | Critical Systems | METHOD AND APPARATUS FOR HEATING TISSUES, IN PARTICULAR FOR TREATMENT OF TUMORS |
Non-Patent Citations (2)
Title |
---|
CA1974 * |
NV8021/67 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2508802A1 (en) * | 1981-07-03 | 1983-01-07 | Thomson Csf | Magnetic powders for use in hyperthermic treatments - e.g. of tumours, heated by hysteresis in alternating magnetic field |
Also Published As
Publication number | Publication date |
---|---|
DE2828941A1 (en) | 1980-01-10 |
DE2828941C2 (en) | 1989-03-16 |
GB2024007B (en) | 1983-04-27 |
FR2429591B1 (en) | 1981-06-26 |
GB2024007A (en) | 1980-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jordan et al. | Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro | |
FR2429591A1 (en) | CANCER TREATMENT METHOD AND COMPOSITION | |
Shintaku et al. | Identification of oncocytic lesions of salivary glands by anti‐mitochondrial immunohistochemistry | |
FR2437837A1 (en) | PROCESS FOR THE PREPARATION OF AN ALLERGEN TREATED WITH AN ALDEHYDE, PRODUCT OBTAINED AND ITS THERAPEUTIC APPLICATION | |
Zupancic | Heterogeneity of uroplakin localization in human normal urothelium, papilloma and papillary carcinoma | |
FR2404289B1 (en) | FERROMAGNETIC METAL PARTICLES ESSENTIALLY COMPOSED OF IRON, AND PROCESS FOR THEIR PREPARATION | |
Alavijeh et al. | Cobalt ferrite decoration of molybdenum disulfide nanosheets; development of a nanocomposite-mediated hyperthermia method | |
BE855833A (en) | PROCESS FOR THE TREATMENT OF STEEL WITH ORIENTAL SILICON AND STEEL THUS OBTAINED | |
BR112022016715A2 (en) | VIRAL VECTORS THAT EXPRESS THERAPEUTIC PROTEINS SPECIFICALLY IN MYELOID CELLS AND MICROGLIA | |
Garin-Chesa et al. | Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems. | |
DE3686811D1 (en) | METHOD AND COMPOSITION FOR TREATING CANCER AND NON-MALIGNAL TUMORS. | |
FR2357514A1 (en) | NEW ODORING SUBSTANCES WITH MUSK ODOR AND PROCESS FOR THEIR PREPARATION | |
DE102015013851B3 (en) | Method for improved magnetic marking of biological materials | |
ES467231A1 (en) | Method of treating molten metal | |
Karewicz et al. | Surface-modified SPION systems for cancer therapy | |
FR1001557A (en) | Process and apparatus for the treatment of phosphate materials, in particular for the manufacture of fertilizers | |
SU96727A1 (en) | The method of diffusion saturation of the surface layers of metal products | |
Kotkas et al. | Autologous mesenchymal stem cells in treatment of liver cirrhosis: evaluation of effectiveness and visualization method | |
SU671848A1 (en) | Magnetic-hydrostatic separator | |
FR919857A (en) | Process for treating metal parts for any coating operation and in particular for enamelling | |
GB737098A (en) | Improvements in or relating to travelling wave linear particle accelerators | |
KR20060058476A (en) | Method for promoting the differentiation of embryonic bodies to hemopoietic stem cells using human bone marrow stromal cells | |
CN112426536B (en) | Magnetic targeting Fe3O4Nano-composite and preparation method and application thereof | |
SU116147A1 (en) | The method of grinding and electrification of synthetic magnetite particles | |
Kaszuba-Zwoińska et al. | Cell viability changes in cultured H4 glioma cells upon low frequency pulsed electromagnetic field (7Hz, 30mT) exposure in flow cytometry analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse | ||
ST | Notification of lapse |